Handheld Raman spectroscopy for ex vivo molecular assessment of cervical lesions: A methodological feasibility study
Year: 2026
Type: article
Abstract: Current diagnostic workflows for cervical lesions remain constrained by processing time, sampling representativeness, and limited molecular-level tissue assessment. Handheld Raman spectroscopy may provide label-free molecular profiling of ex vivo tissue specimens. In this methodological feasibility study, we evaluated a defined ex vivo acquisition workflow using a handheld 785-nm Raman spectrometer. We systematically evaluated laser power, integration time, and tissue thickness, and 128 mW laser power, 4000 ms integration time, and approximately 1-mm-thick tissue sections were selected as the working acquisition conditions for subsequent cervical measurements. The cervical cohort comprised 74 patients contributing 212 Raman spectra and was evaluated for two predefined primary binary classification tasks: invasive cervical cancer versus noncancer lesions (B1) and high-grade squamous intraepithelial lesions (HSIL) versus benign lesions plus low-grade squamous intraepithelial lesions (LSIL) (B2). Exploratory spectrum-level analyses yielded AUCs of 0.774 for B1 and 0.782 for B2. However, under repeated nested patient-grouped cross-validation of the previously selected model families, with all spectra from each patient retained within the same validation fold and hyperparameters optimized using training patients only, the mean patient-level AUC was 0.519 ± 0.051 for B1 and 0.639 ± 0.074 for B2. The corresponding median AUCs were 0.522 (IQR, 0.497-0.545) and 0.642 (IQR, 0.620-0.688), respectively. In patient-aware differential peak analysis, repeated measurements from the same patient were aggregated before statistical testing. Six prespecified Raman bands (1003, 1306, 1341, 1516, 1586, and 1638 cm-¹) remained significant after false discovery rate (FDR) correction for B1, whereas no prespecified band remained significant after FDR correction for B2. These findings support the methodological feasibility of handheld Raman acquisition under the present defined ex vivo workflow and indicate the presence of lesion-associated spectral variation in cervical tissue, while also demonstrating substantial attenuation of classification performance under patient-independent validation. Handheld Raman spectroscopy should therefore currently be regarded as an exploratory adjunctive approach for ex vivo molecular tissue assessment rather than a standalone diagnostic method. Larger patient cohorts, spatially registered Raman-histology validation, fresh-tissue studies, and multicenter external validation are required before clinical translation.
Source: PLoS ONE
Authors: Yixuan Zhang(Conceptualization, Data curation, Formal analysis, Methodology, Software, Writing – original draft), Huan Wang(Validation, Visualization, Writing – original draft, Writing – review & editing), Ying He(Investigation, Project administration), Siyuan Zhang(Project administration, Resources, Software), Pengyu Wang(Validation, Visualization), Yimin Han(Data curation, Funding acquisition, Supervision)
Institution: Harbin Medical University
Language: English
Subfield: Biophysics
Domain: Life Sciences
Keywords: handheld Raman spectroscopy, cervical lesions, cervical cancer, squamous intraepithelial lesions, high-grade squamous intraepithelial lesion, low-grade squamous intraepithelial lesion, ex vivo tissue, spectral classification, diagnostic feasibility, acquisition parameters, tissue thickness, false discovery rate control, cervical cancer screening
Open Access status: gold
Estimated APC paid: $2,382
Award: G9000371579
OpenAlex ID: W7236825279
